In this interview, we sat down with Fadi Roumieh to talk about his journey into medicinal cannabis, how clinician attitudes have shifted over the years, the myths that still surround the industry, and where he sees cannabinoid medicine heading next.

As Australia’s medicinal cannabis sector rapidly expands, regulatory oversight from the TGA is becoming increasingly strict.

Non-compliance carries risks far beyond financial penalties, it can cost businesses their reputation, operational capabilities, and patient trust.

Discover key insights on why robust compliance frameworks are essential for sustainable growth.

Navigating medicinal cannabis compliance in Australia requires more than meeting initial regulatory approvals. As the Therapeutic Goods Administration (TGA) increases its focus on reporting, governance, pharmacovigilance and advertising compliance, businesses must implement strong systems to remain compliant. Learn the essential reporting obligations and best practices for operating successfully in Australia's evolving medicinal cannabis market.

Vertical integration is transforming Australia's medicinal cannabis industry. While connected clinics, pharmacies and patient support can improve access and efficiency, success depends on maintaining clinical independence, strong governance and patient-first care.

We sat down with Penny Murdoch  – a valued team member at EQWELLIBRIYUM, a qualified naturopath, and a medicinal cannabis industry representative – to discuss her unique career journey, the importance of evidence-based education, and how scientific knowledge helps healthcare professionals make informed clinical decisions.

The Department of Veterans Affairs (DVA) updated its Medicinal Cannabis Framework with those changes likely to reshape how clinics deliver care to veteran patients — representing a structural shift in how care must be delivered, documented, and justified under DVA funding pathways.

A case study highlighting an increasingly important reality within the Australian medicinal cannabis industry - that many clinics are operating on inefficient commercial structures without realising stronger opportunities may exist.

Our latest series is all about insights into entering the Australian medicinal cannabis market in 2026. This post breaks down the evolution of the industry from early regulatory barriers to today’s competitive, highly scrutinised landscape and what it signals for the future.

With close to a decade of experience in Australia’s medicinal cannabis industry, Georgie Lutz is a highly respected industry leader and co-founder of Bosman Clinic. We were thrilled to interview her about her journey in the sector, exploring how the industry has evolved and discussing the importance of transparency, clinical independence, and why patient-led models must shape the future of the sector.

Australia’s medicinal cannabis sector is evolving and so are patient expectations.

With patients becoming more informed, more selective, and more willing to change providers if their experience doesn’t meet expectations.In our latest blog, Medicinal Cannabis Patients: Preferences & Perspectives, we explore what patients actually value today and the trends clinics should be preparing for as the market continues to mature.

Whether you're a clinic operator, healthcare professional, or industry stakeholder, understanding these shifts is key to building sustainable, patient-centred care models.

Understanding the patient pathway to medicinal cannabis in Australia can be a major hurdle for businesses . 
Our latest blog post breaks down the entire journey from clinical assessment to TGA approval, highlighting the critical operational frameworks businesses need to support Australian patients effectively.

This article explores the role of pharmacists in dispensing medicinal cannabis, with a focus on patient access, continuity of care, and quality oversight.

Peak a look behind the scenes with our founders Lisa Varley & Tahlia Bavadra discussing their journey into the medicinal cannabis space, industry insights & their vision of the market.

Explore the key rules from governing regulators as it relates to advertising within the medicinal cannabis space to, clarify what clinics and brands can and cannot say, alongside safer strategies to build awareness without risking compliance.

Registered nurses with appropriate training and experience will be able to prescribe medicinal cannabis under a collaborative prescribing model. In this post, we explore how this change brings unprecedented opportunity and responsibility.

For businesses looking to enter or maximise their presence within the medicinal cannabis market, understanding the evolving prescriber landscape and access pathways is crucial to navigate this dynamic market effectively.

Since its legalisation for therapeutic use, Australia’s medicinal cannabis industry has rapidly evolved, marked by complex regulatory changes and a growing infrastructure — making it essential for industry stakeholders to understand the journey of legalisation, its impact on Australian patients, and the diverse ecosystem of stakeholders working to expand access and challenge the lingering stigma surrounding medicinal cannabis.

For healthcare practitioners prescribing or dispensing medicinal cannabis in Australia, it’s essential to understand the varying regulations that can impact patient outcomes — including dispensing substitution policies for these medications.